HTG MOLECULAR DIAGNOSTICS (HTGM) Fundamental Analysis & Valuation

NASDAQ:HTGM • US40434H3021

Current stock price

0.48 USD
-0.12 (-20%)
At close:
0.4815 USD
+0 (+0.31%)
After Hours:

This HTGM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. HTGM Profitability Analysis

1.1 Basic Checks

  • In the past year HTGM has reported negative net income.
  • In the past year HTGM has reported a negative cash flow from operations.
HTGM Yearly Net Income VS EBIT VS OCF VS FCFHTGM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -5M -10M -15M -20M -25M

1.2 Ratios

  • HTGM has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HTGM Yearly ROA, ROE, ROICHTGM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 200 -200 400 -400 600

1.3 Margins

  • With a Gross Margin value of 21.69%, HTGM is not doing good in the industry: 79.55% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of HTGM has declined.
  • HTGM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.29%
GM growth 5Y-15.73%
HTGM Yearly Profit, Operating, Gross MarginsHTGM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300 -400 -500

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. HTGM Health Analysis

2.1 Basic Checks

  • HTGM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, HTGM has more shares outstanding
  • HTGM has a better debt/assets ratio than last year.
HTGM Yearly Shares OutstandingHTGM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M 4M 5M
HTGM Yearly Total Debt VS Total AssetsHTGM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

  • HTGM has an Altman-Z score of -35.30. This is a bad value and indicates that HTGM is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -35.30, HTGM is doing worse than 90.91% of the companies in the same industry.
  • A Debt/Equity ratio of 7.10 is on the high side and indicates that HTGM has dependencies on debt financing.
  • The Debt to Equity ratio of HTGM (7.10) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.1
Debt/FCF N/A
Altman-Z -35.3
ROIC/WACCN/A
WACC4.37%
HTGM Yearly LT Debt VS Equity VS FCFHTGM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M -20M

2.3 Liquidity

  • HTGM has a Current Ratio of 1.40. This is a normal value and indicates that HTGM is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.40, HTGM is not doing good in the industry: 61.36% of the companies in the same industry are doing better.
  • HTGM has a Quick Ratio of 1.30. This is a normal value and indicates that HTGM is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.30, HTGM is doing worse than 61.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 1.3
HTGM Yearly Current Assets VS Current LiabilitesHTGM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. HTGM Growth Analysis

3.1 Past

  • HTGM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.99%, which is quite impressive.
  • Looking at the last year, HTGM shows a very negative growth in Revenue. The Revenue has decreased by -28.21% in the last year.
  • Measured over the past years, HTGM shows a very negative growth in Revenue. The Revenue has been decreasing by -15.48% on average per year.
EPS 1Y (TTM)44.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.54%
Revenue 1Y (TTM)-28.21%
Revenue growth 3Y-30.79%
Revenue growth 5Y-15.48%
Sales Q2Q%-12.83%

3.2 Future

  • The Earnings Per Share is expected to grow by 39.92% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, HTGM will show a very strong growth in Revenue. The Revenue will grow by 53.55% on average per year.
EPS Next Y81.55%
EPS Next 2Y39.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.6%
Revenue Next 2Y53.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HTGM Yearly Revenue VS EstimatesHTGM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HTGM Yearly EPS VS EstimatesHTGM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800

More info and screens

Find the best growth stocksShow best growing peers

1

4. HTGM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HTGM. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HTGM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HTGM Price Earnings VS Forward Price EarningsHTGM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HTGM Per share dataHTGM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as HTGM's earnings are expected to grow with 39.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.92%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HTGM Dividend Analysis

5.1 Amount

  • HTGM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

HTGM Fundamentals: All Metrics, Ratios and Statistics

HTG MOLECULAR DIAGNOSTICS

NASDAQ:HTGM (6/14/2023, 8:00:02 PM)

After market: 0.4815 +0 (+0.31%)

0.48

-0.12 (-20%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-10
Earnings (Next)08-09
Inst Owners0%
Inst Owner Change0%
Ins Owners201.96%
Ins Owner Change0%
Market Cap1.06M
Revenue(TTM)6.21M
Net Income(TTM)-20.15M
Analysts82.86
Price Target6.12 (1175%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-48.59%
Min EPS beat(2)-81.95%
Max EPS beat(2)-15.22%
EPS beat(4)2
Avg EPS beat(4)-14.95%
Min EPS beat(4)-81.95%
Max EPS beat(4)24.87%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-19.27%
Min Revenue beat(2)-36.73%
Max Revenue beat(2)-1.8%
Revenue beat(4)0
Avg Revenue beat(4)-34.25%
Min Revenue beat(4)-56.97%
Max Revenue beat(4)-1.8%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-40%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-162.86%
EPS NY rev (1m)0%
EPS NY rev (3m)-67.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-28.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-34.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 2.24
P/tB 2.24
EV/EBITDA N/A
EPS(TTM)-18.15
EYN/A
EPS(NY)-1.08
Fwd EYN/A
FCF(TTM)-7.61
FCFYN/A
OCF(TTM)-7.6
OCFYN/A
SpS2.81
BVpS0.21
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.69%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.29%
GM growth 5Y-15.73%
F-Score3
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 7.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.28%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 1.3
Altman-Z -35.3
F-Score3
WACC4.37%
ROIC/WACCN/A
Cap/Depr(3y)42.2%
Cap/Depr(5y)55.71%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.54%
EPS Next Y81.55%
EPS Next 2Y39.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-28.21%
Revenue growth 3Y-30.79%
Revenue growth 5Y-15.48%
Sales Q2Q%-12.83%
Revenue Next Year0.6%
Revenue Next 2Y53.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.73%
OCF growth 3YN/A
OCF growth 5YN/A

HTG MOLECULAR DIAGNOSTICS / HTGM Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HTG MOLECULAR DIAGNOSTICS (HTGM) stock?

ChartMill assigns a fundamental rating of 2 / 10 to HTGM.


What is the valuation status for HTGM stock?

ChartMill assigns a valuation rating of 1 / 10 to HTG MOLECULAR DIAGNOSTICS (HTGM). This can be considered as Overvalued.


Can you provide the profitability details for HTG MOLECULAR DIAGNOSTICS?

HTG MOLECULAR DIAGNOSTICS (HTGM) has a profitability rating of 1 / 10.


Can you provide the financial health for HTGM stock?

The financial health rating of HTG MOLECULAR DIAGNOSTICS (HTGM) is 1 / 10.


What is the expected EPS growth for HTG MOLECULAR DIAGNOSTICS (HTGM) stock?

The Earnings per Share (EPS) of HTG MOLECULAR DIAGNOSTICS (HTGM) is expected to grow by 81.55% in the next year.